Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1987
09/22/1987US4695541 Enzymatic detection of bacterial capsular polysaccharide antigens
09/22/1987US4695458 Solution of alpha-chymotrypsin
09/22/1987US4695457 Enzyme composition acting as a digestion promoter on various levels in the alimentary tract, and a method for facilitating digestion
09/22/1987US4695456 Method for alleviating skin irritation by formulations containing superoxide dismutase
09/22/1987CA1227135A1 Nephrotoxicity inhibitors for aminoglycoside antibiotics
09/22/1987CA1227132A1 Preparation having a higher collagenolytic activity and pharmaceutical compositions containing same
09/17/1987DE3641491A1 Pharmaceutical compositions with antitumour action
09/17/1987DE3390272C2 Plasminogen activator useful for thrombolytic drugs - prepd. by column refining of ammonium thiocyanate extract of human kidney or blood vessels
09/16/1987EP0237514A1 Method for enhancing growth of mammary parenchyma
09/16/1987EP0237401A1 Proteins homologous to those coded by human oncogenes, process for obtaning these proteins, and their immunological, physiopathological and therapeutical applications
09/16/1987EP0237398A1 Use of biologically active polypeptides and compositions containing them
09/16/1987EP0237252A2 Methods and compositions relating to regression-associated antigens
09/16/1987EP0237239A2 New compounds
09/16/1987EP0237189A2 Therapeutic and related uses of dithiol peptides
09/16/1987EP0237073A2 IL-1alpha derivatives and drugs
09/16/1987EP0237019A2 Interferon conjugate and production thereof using recombinant gene
09/16/1987EP0236987A2 Chemically modified protein and production thereof
09/16/1987EP0236978A2 Production of factor XIIIa by gene technology
09/16/1987EP0236948A2 Novel compounds WK-142 and process for preparing the same
09/16/1987EP0236920A2 Hybrid interferons, their use as medicaments and as intermediates in the preparation of antibodies, their use and process for their preparation
09/16/1987EP0236872A2 Hydroxyl amine derivatives, their preparation and use as medicaments
09/16/1987EP0236637A1 Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
09/16/1987EP0236619A1 Polypeptide for use in targeting and identifying activated T-lymphocytes
09/16/1987EP0236572A1 Method for healing bone damage and composition
09/16/1987CN87100308A Polypetide compounds
09/16/1987CN86105436A Modulation of aids virus-related events by double-stuanded rnas
09/15/1987US4694069 Antibiotics
09/15/1987US4693998 Novel compounds of the muramyl peptide
09/15/1987US4693993 Bradykinin antagonist peptides
09/15/1987US4693992 Veterinary medicine
09/15/1987US4693973 DNA sequences, recombinant DNA molecules and processes for producing bovine growth hormone-like polypeptides in high yield
09/15/1987US4693966 Binding antigens on cell surfaces
09/15/1987US4693885 Tetrapyrrole therapeutic agents
09/15/1987US4693718 Stimulation of chemotaxis by chemotactic peptides
09/15/1987US4692459 Anti-hypertensive agents
09/15/1987CA1226815A1 Slow-release composite and process for producing the same
09/11/1987WO1987005399A1 Method of detecting antibody against htlv-iii
09/11/1987WO1987005332A1 Recombinant human endothelial cell growth factor
09/11/1987WO1987005326A1 Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
09/11/1987WO1987005301A1 Methods and compositions relating to regression-associated antigens
09/11/1987WO1987005300A2 Protein preservation
09/11/1987WO1987005221A1 Methods and materials for treatment of rheumatoid arthritis
09/11/1987WO1987005219A1 Pharmaceutical preparation containing a dipeptide with cell growth regultating effect
09/09/1987EP0236289A2 Tissue plasminogen activator from normal human colon cells
09/09/1987EP0236164A1 Derivatives of N-alpha-arylsolfonylaminoacyl p-amidino-phenylalaninamides, process for their preparation, their use as medicaments and their intermediates
09/09/1987EP0236163A1 Derivatives of N-alpha-substituted N-alpha-arylsulfonylaminoacyl p-amidinophenylalaninamides, their preparation, their use as medicaments and their intermediates
09/09/1987EP0236145A1 Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
09/09/1987EP0236040A2 Amino acid modified prourokinase and method of preparation
09/09/1987EP0235906A1 Method and composition for prophylaxis and treatment of viral infections
09/09/1987EP0235904A2 Treatment of allergy with thymopentin
09/09/1987EP0235805A2 Improvements relating to immunosuppression
09/09/1987EP0235692A2 Oligopeptidyl nitrile derivatives, the agents containing them, process for their preparation and their use
09/09/1987EP0235661A2 Heterocyclic compounds with a 2-[2-(N,N-bis-(2-chloroethyl)-diamido-phosphoryl-oxy)ethyl] rest
09/09/1987EP0235410A1 Prokaryotic expression system
09/09/1987EP0235391A2 Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
09/09/1987EP0235187A1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used.
09/08/1987US4692522 Benzofused lactams useful as cholecystokinin antagonists
09/08/1987US4692511 Peptide antagonists for the C5a anaphylatoxin
09/08/1987US4692458 Anti-hypertensive agents
09/08/1987US4692437 Anti-hypertensive agents
09/08/1987US4692433 Adminstering a polypeptide hormone encapsulated in a liposome
09/08/1987US4692332 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
09/03/1987DE3641379A1 Medicaments
09/03/1987DE3606798A1 Composition and method for the treatment of coronary disorders or organic brain syndrome
09/02/1987EP0235116A2 Deactivated protein derivatives
09/02/1987EP0234946A2 New compounds
09/02/1987EP0234935A2 Vasopressin compounds
09/02/1987EP0234919A2 Lipid composition
09/02/1987EP0234855A2 Preparation for stimulation of tear secretion with melanocyte stimulating hormones
09/02/1987EP0234599A1 Cysteine-depleted muteins of interleukin-2, their preparation, formulations containing them, and genes, vectors and organisms suitable for use in the preparation of said muteins
09/02/1987EP0234545A2 Purified human angiogenic factor, method for its preparation and pharmaceutical preparations
09/02/1987EP0234405A2 Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human
09/02/1987EP0234186A1 Use of oligopeptids for the treatment of cerebral disorders
09/02/1987EP0234178A1 New 8-substituted derivatives of an anhydrooctonic acid, methods for their preparation, pharmaceutical preparations containing these and intermediates
09/02/1987EP0234151A1 Glycoproteins modified by oxidation and formation of Schiff bases, inhibiting ribosomes, process for obtaining the same, and immunotoxines containing such glycoprotein
09/02/1987EP0234122A2 Tumor therapy with biologically active anti-tumor antibodies
09/02/1987EP0234051A1 Tissue-type plasminogen activator mutants; recombinant genetic information coding therefor and process for preparing said mutants; their use and pharmaceutical compositions
09/02/1987EP0154625A4 Hybridoma cell line producing suppressive factor of allergy.
09/02/1987CN87100769A Heterocyclic compounds having 2-(2-(n,n-bis-(2-chloroethyl)-diamidophosphoryloxy)-ethyl) radical
09/01/1987US4691049 Process for preparing a specific diastereomer of a monoamino dicarboxylic acid ester
09/01/1987US4691024 Bactericides, antitumor
09/01/1987US4691010 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, and methods
09/01/1987US4691009 Hybrid proteins produced by an ultrahigh prokaryotic expression system
09/01/1987US4691008 Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process
09/01/1987US4691007 Human leukocyte elastase inhibitors
09/01/1987US4691006 Antigenic modification of polypeptides
09/01/1987US4690952 Pharmaceutical compositions for nasal administration comprising calcitonin and an absorption-promoting substance
09/01/1987US4690940 Anti-hypertensive agents
09/01/1987US4690939 Anti-hypertensive agents
09/01/1987US4690938 Anti-hypertensive agents
09/01/1987US4690937 Anti-hypertensive agents
09/01/1987US4690936 Anti-hypertensive agents
09/01/1987US4690916 Nona and decapeptide analogs of LHRH useful as LHRH antagonists
09/01/1987US4690915 Administering interleukin and activated lymphocytes
08/1987
08/27/1987WO1987005048A1 Plasmids which inhibit human t-cell lymphotropic virus type iii replication
08/27/1987WO1987005029A2 Peptides affecting blood pressure regulation
08/27/1987WO1987004925A1 Stimulation of angiogenesis
08/27/1987DE3704196A1 Novel heterocyclic compounds containing a 2-{2-[N,N-bis-(2-chloroethyl)diamidophosphoryloxy]ethyl} radical
08/27/1987DE3601562A1 Use of amino-acid derivatives for the treatment of coronary disorders and organic brain syndrome
08/26/1987EP0233838A2 Neurite-promoting factor and process for the manufacture thereof